Amy Burroughs

President & CEO at Cleave Therapeutics

No bio yet


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Cleave Therapeutics

Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.


Employees

1-10

Links